Q1 2025 Financial Summary
Alvio Labs | Period: Jan 1 – Mar 31, 2025
Report Date: Mar 22, 2026
Currency: EUR
Net Loss
-€10,967
Cash Position
€532
Total Expenses
€10,967
Net Liquidity
€126
Director Funding
€14,543

Executive Summary

This report summarizes the financial performance of Alvio Labs for Q1 2025 (January 1 – March 31, 2025). The company reported a net loss of €10,966.85, driven primarily by cost of goods sold (€10,350) and operating expenses (€617). No revenue was recorded during this period, indicating the company remains in a pre-revenue development phase. Cash position stands at €532.14 with net liquidity of €126.24 after accounting for outstanding payables. The company has received significant director funding totaling €14,543.09 to support operations.

Profit & Loss Statement

ItemEUR
Revenue
Sales Revenue€0.00
Total Revenue€0.00
Cost of Sales
Cost of Goods Sold€10,350.00
Total Cost of Sales€10,350.00
Gross Profit-€10,350.00
Operating Expenses
Bank Fees€10.00
Consulting & Accounting€405.90
Software Expenses€2.68
R&D€198.27
Total Operating Expenses€616.85
Net Loss-€10,966.85

Balance Sheet (Mar 31, 2025)

Item20252024
ASSETS
Cash - Revolut EUR€532.14€0.00
Total Assets€532.14€0.00
LIABILITIES
Accounts Payable€405.90€0.00
Director's Current A/c€13,993.09€0.00
Director's Loan A/c€550.00€0.00
Total Liabilities€14,948.99€0.00
NET ASSETS-€14,416.85€0.00

Cash Position

MetricEUR
Cash at Bank€532.14
Outstanding Receivables€0.00
Outstanding Payables€405.90
Net Liquidity€126.24

Key Observations

Revenue: No revenue recorded in Q1 2025; company is in pre-revenue/development phase with focus on product development.

Expenses: Total expenses of €10,966.85 incurred, primarily cost of goods sold (€10,350) and operating expenses (€617). Major operating costs: consulting & accounting (€406) and R&D (€198).

Cash Position: Minimal cash balance of €532.14 with net liquidity of €126.24 after payables. Requires careful cash flow management.

Director's Funding: Significant director contributions via current account (€13,993) and loan account (€550) totaling €14,543 to support operations.

Q1 2025 Detailed Analysis
Alvio Labs | Supporting Schedules & Transaction Details
Page: 2 of 2
Currency: EUR

Operating Expense Breakdown

CategoryAmount (EUR)% of Total
Consulting & Accounting€405.9065.8%
Research & Development€198.2732.1%
Bank Fees€10.001.6%
Software Expenses€2.680.4%
Total Operating Expenses€616.85100%

Cost of Goods Sold Detail

DescriptionAmount (EUR)
Development Costs - Sqillx Education€10,350.00
Total Cost of Goods Sold€10,350.00

Director Funding Summary

TypeAmount (EUR)
Director's Current Account€13,993.09
Director's Loan Account€550.00
Total Director Funding€14,543.09

Q1 2025 Bank Transactions Summary

TypeCountAmount (EUR)
Director Loans (Receipts)2€550.00
Bank Fees (Revolut)1-€10.00
Software/Tool Purchases1-€5.18
Net Bank Activity4€534.82

Major Vendor Payments (Q1 2025)

VendorDescriptionAmount (EUR)Date
Sqillx Education Private LimitedFull-Stack Engineer / Development Services€3,450.00Jan 1, 2025
Sqillx Education Private LimitedDevelopment Services€3,450.00Feb 1, 2025
Sqillx Education Private LimitedDevelopment Services€3,450.00Mar 1, 2025
Around FinanceAnnual Accounts & Corporation Tax Return€135.30Jan 1, 2025
Around FinanceAnnual Accounts & Corporation Tax Return€135.30Feb 1, 2025
Around Finance€135.30Mar 1, 2025
Secret (Tech Lab SAS)Services€193.09Feb 8, 2025
Total Major Payments€10,948.99

Financial Ratios & Metrics

Liquidity

Current Ratio0.04
Quick Ratio0.04
Cash Ratio0.04

Leverage

Debt-to-Assets28.1x
Debt-to-EquityN/A
Net Debt€14,417

Activity

Monthly Burn Rate€3,656
Runway (months)0.1
Expenses/RevenueN/A

Risk Assessment & Recommendations

Liquidity Risk (HIGH): With net liquidity of only €126.24 and monthly burn rate of approximately €3,656, the company has less than one month of runway. Immediate funding or revenue generation is critical.

Dependency Risk (HIGH): Heavy reliance on director funding (€14,543) indicates unsustainable financing structure. Need to establish revenue streams or external funding.

Recommendation: 1) Accelerate revenue generation activities; 2) Secure additional funding or reduce burn rate; 3) Monitor cash position weekly; 4) Consider cost optimization in non-critical areas.

Notes: 1) All figures in EUR. 2) Data sourced from Xero as of Mar 22, 2026. 3) Period: Jan 1 – Mar 31, 2025. 4) Ratios calculated based on period-end balance sheet. 5) Burn rate calculated as Q1 total expenses divided by 3 months.